Characterization of 47 MHC class I sequences in Filipino cynomolgus macaques

Kevin J Campbell1, Ann M Detmer, Julie A Karl

  • 1Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53706, USA.

Immunogenetics
|December 25, 2008
PubMed

Insights

Filipino cynomolgus macaques possess unique MHC class I sequences, with some shared haplotypes offering potential protection against simian immunodeficiency virus (SIV) and simian-human immunodeficiency virus (SHIV). This genetic diversity impacts their use in infectious disease research.

Area of Science:

  • Genetics and Immunology
  • Primate Models in Research

Background:

  • Cynomolgus macaques are vital models for infectious disease research, but genetic variations between populations are often overlooked.
  • Host genetics significantly influence pathogenesis studies, necessitating a deeper understanding of macaque population genetics.

Purpose of the Study:

  • To characterize the Major Histocompatibility Complex (MHC) class I nucleotide sequences in Filipino cynomolgus macaques.
  • To compare these sequences with those from other macaque populations and assess implications for SIV/SHIV research.

Main Methods:

  • Sequencing of 47 full-length MHC class I nucleotide sequences from 16 Filipino cynomolgus macaques.
  • Bioinformatic analysis to identify unique and shared sequences and haplotypes.

Main Results:

  • 39 of 47 MHC class I sequences were unique to the Filipino population.
  • Identified two shared ancestral MHC haplotypes between Filipino and Mauritian macaques, including a protective Mafa-B haplotype.
  • Discovered a Filipino MHC class I sequence differing by one amino acid from Mamu-B*17, associated with SIV protection.

Conclusions:

  • Filipino cynomolgus macaques exhibit significant MHC class I genetic diversity.
  • Shared haplotypes suggest evolutionary connections and potential for cross-population protection insights.
  • Findings are crucial for optimizing the use of Filipino macaques in SIV/SHIV pathogenesis and vaccine research.